RARE DISEASERESEARCH ATLAS

ORPHA:2077

German syndrome

medium confidence

Also known as: Hypotonia-arthrogryposis-facial dysmorphism-lymphedema syndrome

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Clinical definition (Orphanet)

German syndrome is an arthrogryposis syndrome, described in 5 cases. Three of the four known families with affected children were Ashkenazi Jews. German syndrome is characterized by arthrogryposis, -hypokinesia sequence, and lymphedema. Patients present distinct craniofacial appearance (tall forehead and ''carp''-shaped mouth, cleft palate), contractures, severe manifesting as motor delay, and swallowing difficulties. The disease has a severe morbidity and mortality rate and survivors present a small stature, , frequent upper respiratory infections, and psychomotor delay. There have been no further descriptions in the literature since 1987.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Is anyone studying this?

4

4 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=183) is 38.

4 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 38 (publications denominator n=183).

0 in the last 10 years · medium confidence · 2.5th percentile (publications denominator)

Is a treatment being tested?

0

trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 26 July 2026

No matched interventional trials. This is true for 59.2% of diseases in the trials denominator (151 of 255). Here are the researchers publishing on it.

medium confidence · 29.6th percentile (trials denominator)

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Who's working on it?

8

Distinct author names in 4 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Bellini C1 paper · 2006

    Neonatal Intensive Care Unit, Department of Pediatrics, University of Genoa, G, Gaslini Institute, Genoa, Italy. carlobellini@ospedale-gaslini.ge.it

    Papers in Europe PMC
  2. 02
    Benson MD1 paper · 1991

    Department of Medicine, Indiana University School of Medicine, Indianapolis 46223.

    Papers in Europe PMC
  3. 03
    Boccardo F1 paper · 2006
    Papers in Europe PMC
  4. 04
    Bonioli E1 paper · 2006
    Papers in Europe PMC
  5. 05
    Campisi C1 paper · 2006
    Papers in Europe PMC
  6. 06
    Hughes HE1 paper · 1987
    Papers in Europe PMC
  7. 07
    Leiber B1 paper · 1975
    Papers in Europe PMC
  8. 08
    Lewin SO1 paper · 1987
    Papers in Europe PMC

Recruiting interventional trials

Trials testing a treatment from the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it above — people publishing on this disease are often the practical next contact when no trial is listed.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.

"German syndrome" OR "Hypotonia-arthrogryposis-facial dysmorphism-lymphedema syndrome"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: German Syndrome

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"German syndrome" OR "Hypotonia-arthrogryposis-facial dysmorphism-lymphedema syndrome"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Cross-references (from Mondo): MESH:C562543 OMIM:231080 UMLS:C3887495

Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is short or not clearly distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Report an error for ORPHA:2077